Distributor sought for disruptive malaria diagnostic kits in malaria-ridden countries

A Swiss deep-tech spin-off offers a novel malaria diagnostic that is based on a patented and published amplification of a pan-malarial biomarker. The diagnostic kit can detect asymptomatic carriers due to its high sensitivity. The diagnostic is fast and easy to use and can also be used as a screening tool. The target markets are malaria-ridden countries, where P.vivax malaria parasites are dominant. The company is seeking business partners for distribution services agreements or joint ventures.